Related by context. Frequent words. (Click for all words.) 67 RECIST criteria 63 evaluable patients 62 cytogenetic response 60 evaluable 59 RECIST 58 neoadjuvant chemotherapy 57 metastatic renal cell carcinoma 56 mg kg dose 55 median PFS 55 HER2 negative 55 sustained virologic response 55 relapsed refractory 54 tumor recurrence 54 nab paclitaxel 54 chemoradiation 54 HER2 + 54 neoadjuvant 54 tumor shrinkage 53 liver metastases 53 annualized relapse 53 gefitinib 53 free survival PFS 53 placebo p = 52 Erlotinib 52 dose cohorts 52 ACTH 52 dasatinib 52 pg mL 52 tumor regression 52 adalimumab 52 nilotinib 52 nonresponders 52 Sorafenib 52 imatinib 52 febrile neutropenia 52 mitoxantrone 51 axitinib 51 STELARA 51 decitabine 51 vandetanib 51 Gemcitabine 51 Rituximab 51 HER-2/neu 51 seroconversion 51 virologic failure 51 allogeneic stem cell 50 fluorouracil 50 hypercalcemia 50 infliximab 50 Cetuximab 50 Median survival 50 plus ribavirin 50 mg BID 50 Taxotere ® 50 azacitidine 50 peginterferon 50 diagnosed multiple myeloma 50 IMGN# 50 peginterferon alfa 2b 50 noninferiority 50 sunitinib 50 FOLFIRI 50 COPAXONE ® 50 follicular lymphoma 50 tamoxifen therapy 49 SCH # 49 undetectable viral load 49 PCa 49 Imatinib 49 biologic therapy 49 adefovir 49 interferon alfa 49 dacarbazine 49 Torisel 49 FOLFOX 49 PegIntron 49 anti TNF 49 peginterferon alfa 2a 49 CMV infection 49 bone metastasis 49 temsirolimus 49 VIDAZA 49 Jevtana 49 prespecified 49 plus methotrexate 48 unresectable 48 HRPC 48 etoposide 48 HCV infected 48 entecavir 48 exemestane 48 confidence interval #.#-#.# 48 refractory multiple myeloma 48 nephrectomy 48 TORISEL 48 neutralizing antibody 48 DMARD 48 imatinib mesylate 48 mcg kg 48 seliciclib 48 BMS #